Marius Pharmaceuticals, Inc. today announced the company will initiate a new post-marketing clinical study for potential label expansion evaluating KYZATREX® (testosterone undecanoate) CIII capsules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback